Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The human C3b receptor.

J Cook, M Kazatchkine

    Nouvelle Revue Francaise D'Hematologie
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    The C3b receptor, a glycoprotein, inhibits complement activation and aids in immune complex breakdown. Low C3b receptor levels are linked to immune complex diseases like lupus.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the sixth international EUFEPS/PQRI conference.

    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2025
    Same author

    Estimating the Age of Disease-causal HPV Infection Based on the Natural History of CIN2+ Among Females in Canada.

    Open forum infectious diseases·2025
    Same author

    Psychosocial outcomes after varying risk management strategies in women at increased familial breast cancer risk: a mixed methods study of patient and partner outcomes.

    Annals of the Royal College of Surgeons of England·2023
    Same author

    Drug Permeability - Best Practices for Biopharmaceutics Classification System (BCS)-Based Biowaivers: A workshop Summary Report.

    Journal of pharmaceutical sciences·2023
    Same author

    Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes.

    Annals of oncology : official journal of the European Society for Medical Oncology·2022
    Same author

    Corrigenda.

    The bone & joint journal·2021
    Same journal

    XIVth Congress of the French Society of Hematology. Paris, France, February 3-4, 1995. Abstracts.

    Nouvelle revue francaise d'hematologie·1995
    Same journal

    Improved detection of CD2 on formaldehyde-fixed non dehydrated cells.

    Nouvelle revue francaise d'hematologie·1995
    Same journal

    Engraftment of CD34+ peripheral blood progenitor cells into multiple myeloma patients following total body irradiation.

    Nouvelle revue francaise d'hematologie·1995
    Same journal

    Allogeneic transplantation of peripheral blood progenitor cells.

    Nouvelle revue francaise d'hematologie·1995
    Same journal

    Selection and expansion of CD34+ cells.

    Nouvelle revue francaise d'hematologie·1995
    Same journal

    Ex vivo hematopoietic cell expansion: a theoretical and technological challenge.

    Nouvelle revue francaise d'hematologie·1995
    See all related articles

    Area of Science:

    • Immunology
    • Molecular Biology
    • Cell Biology

    Background:

    • The complement system is crucial for innate and adaptive immunity.
    • The C3b fragment plays a central role in complement activation.
    • Cellular receptors for complement components are vital for immune cell function.

    Purpose of the Study:

    • To characterize the cellular receptor for the C3b fragment.
    • To investigate the functional role of the C3b receptor in immune responses.
    • To explore the association between C3b receptor expression and immune complex diseases.

    Main Methods:

    • Biochemical characterization of the C3b receptor (molecular weight, glycoprotein nature).
    • Analysis of C3b receptor expression on various cell types (erythrocytes, leukocytes, lymphocytes, podocytes).

    Related Experiment Videos

  • Functional assays assessing the receptor's role in complement inhibition, C3b degradation, and phagocytosis.

    • Main Results:

    • Identified a 205,000 MW glycoprotein as the C3b receptor.
    • Demonstrated the receptor's potent inhibition of both classical and alternative complement pathways.
    • Showed the receptor enhances phagocytosis and ligand internalization in neutrophils and monocytes.
    • Found genetically determined, low C3b receptor expression on erythrocytes in systemic lupus erythematosus patients.
    • Observed low kidney C3b receptor numbers in non-systemic lupus erythematosus nephritis.

    Conclusions:

    • The C3b receptor is a key regulator of complement activation and immune complex processing.
    • Abnormalities in C3b receptor expression, particularly low levels, may predispose individuals to immune complex diseases.
    • Further research into C3b receptor function could offer insights into disease pathogenesis and therapeutic targets.